Christiana Stamoulis, SVP, Corporate Strategy & Business Devlp at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 4,687 shares at $81.42 ($381K) on 2013-07-05, disclosed to the SEC on 2013-07-09.
Scheduled sale ($381k) by SVP, Corporate Strategy & Business Devlp under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.65 | 1,300 | $105K | 27.5% |
| 2 | $81.42 | 3,387 | $276K | 72.5% |
| Total | $81.21 avg | 4,687 | $381K | 100% |
| Filing → |
| HOLX | SELL | 2020-11-06 | $825K | — | Filing → |
| HOLX | SELL | 2019-11-26 | $1.2M | — | Filing → |
| HOLX | SELL | 2018-11-30 | $1.2M | — | Filing → |